GlassScriptPhysician profile
Austin L Rivett
NPI 1225003627
$4,088.67
in general payments reported to CMS, 2019-2025
36 companies · $931 in 2025
The $931 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.60 · 2021: $347 · 2022: $901 · 2023: $1,115 · 2024: $744 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,790.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $823.16 | 2021-2025 | Qulipta, Vraylar, Linzess |
| Lilly USA, LLC | $554.74 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $536.66 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $349.23 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $181.05 | 2021-2025 | Invega Sustenna, Xarelto, Spravato |
| Otsuka America Pharmaceutical, INC. | $173.34 | 2021-2025 | Rexulti |
| Abbott Laboratories | $141.52 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Axsome Therapeutics, INC. | $141.29 | 2023-2025 | Sunosi |
| Astrazeneca Pharmaceuticals LP | $135.49 | 2021-2025 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $134.51 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $96.32 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $81.90 | 2023-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $74.01 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Biohaven Pharmaceutical Holding Company LTD. | $71.06 | 2022 | |
| Amgen INC. | $64.58 | 2022-2025 | Evenity, Otezla, Repatha |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Rivett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.